(I-BusinessNews.Com, July 07, 2021 ) HIV drug manufacturing companies are increasingly adopting 3D bioprinting technology in the development and manufacturing processes of HIV drugs to reduce manufacturing costs and increase production efficiencies and expedite the process of drug discovery. 3D bioprinting is a manufacturing process where a 3D structure of the tissue is created using bio-ink. Bio-inks are materials which are used to produce artificial live tissues using 3D printing. For instance, Viiv Healthcare Limited, a USA-based pharmaceutical company specializing in developing HIV therapies is using HP’s D300 for creating latency reversal drugs for HIV. Moreover, companies are continuously manufacturing 3D bioprinters for overcoming technical limitations plaguing pharmaceutical research, regenerative medicine, and tissue engineering.
The HIV drugs market consists of sales of Human Immunodeficiency Virus (HIV) drugs used for the treatment of HIV infection/AIDS. The market consists of revenue generated by the antiretroviral drug companies manufacturing the anti-retroviral drugs such as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry and fusion inhibitors, integrase inhibitors, and protease inhibitors (PIs) for the treatment of HIV infection.
HIV Drugs Market Report Segments:
1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRTs), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRTs), Protease Inhibitors, Integrate Inhibitors, Fusion Inhibitors, Chemokine Receptor Inhibitors, Others
2) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
3) By Administration: Oral, Parenteral
Read More On The Global HIV Drugs Market Report:
HIV Drugs Market Size Forecast:
The global HIV drugs market is expected to grow from $30.52 billion in 2020 to $31.28 billion in 2021 at a compound annual growth rate (CAGR) of 2.5%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $36.46 billion in 2025 at a CAGR of 3.9%.
Major Players in the HIV Drugs Market:
Merck & Co., Inc.
Bristol-Myers Squibb Company
Request For A Sample:
HIV Drugs Market – By Type (Nucleoside Reverse Transcriptase Inhibitors (NRTÂs), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRTÂs), Protease Inhibitors, Integrase Strand Transfer Inhibitors (INSTIs), Others ) By Application (Hospital Pharmacies, Retail Pharmacies, Others) By Administration (Oral, Parenteral) And By Region, Opportunities And Strategies Â Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provide market overviews, analyze and forecast market size and growth for the whole market, HIV drugs market segments and geographies, HIV drugs market trends, drivers, restraints, leading competitorsÂ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.
The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitorsÂ approaches.
Here Is A List Of Reports Similar To The HIV Drugs Global Market Report By The Business Research Company:
Pharmaceutical Drugs Market – By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies Â Global Forecast To 2030
Ophthalmology Drugs Market – By Type (Anti-glaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies Â Global Forecast To 2030
Oncology Drugs Market – By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid Cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies – Global Forecast To 2030
Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
The Business Research Company